164 related articles for article (PubMed ID: 38764063)
1. The Ethics of Decentralized Clinical Trials and Informed Consent: Taking Technologies' Soft Impacts into Account.
van Rijssel TI; van Thiel GJMW; van Delden JJM;
Health Care Anal; 2024 May; ():. PubMed ID: 38764063
[TBL] [Abstract][Full Text] [Related]
2. Decentralized clinical trials (DCTs): A few ethical considerations.
Petrini C; Mannelli C; Riva L; Gainotti S; Gussoni G
Front Public Health; 2022; 10():1081150. PubMed ID: 36590004
[TBL] [Abstract][Full Text] [Related]
3. Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics review.
van Rijssel TI; de Jong AJ; Santa-Ana-Tellez Y; Boeckhout M; Zuidgeest MGP; van Thiel GJMW;
Drug Discov Today; 2022 Oct; 27(10):103326. PubMed ID: 35870693
[TBL] [Abstract][Full Text] [Related]
4. Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative.
Apostolaros M; Babaian D; Corneli A; Forrest A; Hamre G; Hewett J; Podolsky L; Popat V; Randall P
Ther Innov Regul Sci; 2020 Jul; 54(4):779-787. PubMed ID: 32557302
[TBL] [Abstract][Full Text] [Related]
5. Design and Execution of Sustainable Decentralized Clinical Trials.
Singh P; Burden AM; Natanegara F; Beckman RA
Clin Pharmacol Ther; 2023 Oct; 114(4):802-809. PubMed ID: 37489911
[TBL] [Abstract][Full Text] [Related]
6. Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation.
Goldstein CE; Weijer C; Brehaut JC; Fergusson DA; Grimshaw JM; Horn AR; Taljaard M
BMC Med Ethics; 2018 Feb; 19(1):14. PubMed ID: 29482537
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.
Nicholls SG; Carroll K; Zwarenstein M; Brehaut JC; Weijer C; Hey SP; Goldstein CE; Graham ID; Grimshaw JM; McKenzie JE; Fergusson DA; Taljaard M;
Trials; 2019 Dec; 20(1):765. PubMed ID: 31870433
[TBL] [Abstract][Full Text] [Related]
9. Assessing the Financial Value of Decentralized Clinical Trials.
DiMasi JA; Smith Z; Oakley-Girvan I; Mackinnon A; Costello M; Tenaerts P; Getz KA
Ther Innov Regul Sci; 2023 Mar; 57(2):209-219. PubMed ID: 36104654
[TBL] [Abstract][Full Text] [Related]
10. Researchers' perceptions of ethical challenges in cluster randomized trials: a qualitative analysis.
McRae AD; Bennett C; Brown JB; Weijer C; Boruch R; Brehaut J; Chaudhry S; Donner A; Eccles M; Grimshaw J; Zwarenstein M; Taljaard M
Trials; 2013 Jan; 14():1. PubMed ID: 23286245
[TBL] [Abstract][Full Text] [Related]
11. Application of Internet of Medical/Health Things to Decentralized Clinical Trials: Development Status and Regulatory Considerations.
Sato T; Ishimaru H; Takata T; Sasaki H; Shikano M
Front Med (Lausanne); 2022; 9():903188. PubMed ID: 35733872
[TBL] [Abstract][Full Text] [Related]
12. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
13. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
14. A secondary qualitative analysis of stakeholder views about participant recruitment, retention, and adherence in decentralised clinical trials (DCTs).
Coyle J; Rogers A; Copland R; De Paoli G; MacDonald TM; Mackenzie IS;
Trials; 2022 Jul; 23(1):614. PubMed ID: 35907888
[TBL] [Abstract][Full Text] [Related]
15. Researcher and study participants' perspectives of consent in clinical studies in four referral hospitals in Vietnam.
Van Nuil JI; Nguyen TTT; Le Nguyen TN; Nguyen VVC; Chambers M; Ta TDN; Merson L; Nguyen TPD; Hoang MTV; Parker M; Bull S; Kestelyn E
BMC Med Ethics; 2020 Jan; 21(1):4. PubMed ID: 31924199
[TBL] [Abstract][Full Text] [Related]
16. Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspective.
de Jong AJ; Shahid N; Zuidgeest MGP; Santa-Ana-Tellez Y; Hogervorst M; Goettsch W; Traore H; de Boer A; Gardarsdottir H;
Value Health; 2024 Mar; 27(3):294-300. PubMed ID: 38043711
[TBL] [Abstract][Full Text] [Related]
17. Inadequacy of ethical conduct and reporting of stepped wedge cluster randomized trials: Results from a systematic review.
Taljaard M; Hemming K; Shah L; Giraudeau B; Grimshaw JM; Weijer C
Clin Trials; 2017 Aug; 14(4):333-341. PubMed ID: 28393537
[TBL] [Abstract][Full Text] [Related]
18. "A Question of Trust" and "a Leap of Faith"-Study Participants' Perspectives on Consent, Privacy, and Trust in Smart Home Research: Qualitative Study.
Kennedy MR; Huxtable R; Birchley G; Ives J; Craddock I
JMIR Mhealth Uhealth; 2021 Nov; 9(11):e25227. PubMed ID: 34842551
[TBL] [Abstract][Full Text] [Related]
19. The landscape of decentralized clinical trials (DCTs): focusing on the FDA and EMA guidance.
Park J; Huh KY; Chung WK; Yu KS
Transl Clin Pharmacol; 2024 Mar; 32(1):41-51. PubMed ID: 38586122
[TBL] [Abstract][Full Text] [Related]
20. Ethical communication in clinical trials. Issues faced by data managers in obtaining informed consent.
Loh WY; Butow PN; Brown RF; Boyle F
Cancer; 2002 Dec; 95(11):2414-21. PubMed ID: 12436450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
